title: Haemolytic uraemic syndrome in a renal transplant recipient during OKT3 therapy.
authors.affiliation: Service de Néphrologie et Hémodialyse, Hôpital Sainte-Marguerite, France.
authors.forename: B
authors.initials: B
authors.lastname: Dussol
authors.forename: P
authors.initials: P
authors.lastname: Brunet
authors.forename: H
authors.initials: H
authors.lastname: Vacher-Coponat
authors.forename: Y
authors.initials: Y
authors.lastname: Saingra
authors.forename: P
authors.initials: P
authors.lastname: Casanova
authors.forename: Y
authors.initials: Y
authors.lastname: Berland
mesh_terms: D000328:Adult; D006085:Graft Survival; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000473:pathology; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects*
chemical_list: D016853:Muromonab-CD3